COPD
Top Five Articles on 360Dx Last Week: Test for COPD Flare-Ups; Clinical Use of Wearable Techs; More
Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.
The company analyzes urine samples using a lateral flow test and optical reader combined with artificial intelligence to predict lung disease exacerbations.
BioAffinity Aims to Make Lung Cancer Test Available Nationally Following Pathology Lab Acquisition
Premium
With the acquisition of Precision Pathology Services, BioAffinity plans on expanding the availability of the CyPath Lung LDT nationwide next year.
In a bid to expand recognition and treatment of alpha-1 antitrypsin deficiency, a cause of COPD, Grifols is making its over-the-counter genetic test available for free.
The breath-based biopsy firm is collaborating with Renji Hospital to conduct a clinical trial into the early detection of lung cancer in China.